US 11793855
TFPI inhibitors and methods of use
granted A61KA61K2121/00A61K38/00
Quick answer
US patent 11793855 (TFPI inhibitors and methods of use) held by Takeda Pharmaceutical Company Limited expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Oct 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K2121/00, A61K38/00, A61K38/10, A61P